Norbert Hilf, Ph.D.

Vice President
Translational Development

Norbert Hilf is heading the Department of Translational Development responsible for the transition of R&D projects into preclinical and finally clinical first-in-human stage. Further, his department is performing Project Management for internal programs as well as Industry Partnerships and oversees R&D Strategy and Communications, and Biosample Logistics. Norbert is also coordinating the development of Immatics’ global QM systems.

Since he joined Immatics in 2004, he engaged in R&D projects as a science-driven Immunologist. Norbert’s department gained expertise in the development of multi-peptide cancers vaccines, actively personalized immunotherapies, adoptive cellular therapies, and bispecific T-cell receptors - from the preclinical stage up to Phase I clinical trials.

Norbert Hilf studied biochemistry at the University of Tübingen and holds a doctoral degree in Biochemistry / Immunology. For his thesis, he joined Hans-Georg Rammensee’s group and worked on links between innate and adaptive immunity.

Back

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close